HEADER VIRAL PROTEIN/INHIBITOR 13-JAN-22 7TIA
TITLE CRYSTAL STRUCTURE OF SARS-COV-2 3CL IN COMPLEX WITH INHIBITOR NK01-14
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: 3C-LIKE PROTEINASE NSP5;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: 3CL-PRO,3CLP,MAIN PROTEASE,MPRO,NON-STRUCTURAL PROTEIN 5,
COMPND 5 NSP5,SARS CORONAVIRUS MAIN PROTEINASE;
COMPND 6 EC: 3.4.22.69;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS
SOURCE 3 2;
SOURCE 4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2;
SOURCE 5 ORGANISM_TAXID: 2697049;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS VIRAL PROTEIN, VIRAL PROTEIN-INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR F.FOROUHAR,H.LIU,S.IKETANI,A.ZACK,N.KHANIZEMAN,E.BEDNAROVA,B.FOWLER,
AUTHOR 2 S.J.HONG,H.MOHRI,M.S.NAIR,Y.HUANG,N.E.S.TAY,S.LEE,C.KARAN,
AUTHOR 3 S.J.RESNICK,C.QUINN,W.LI,H.SHION,C.JURTSCHENKO,M.A.LAUBER,
AUTHOR 4 T.MCDONALD,M.E.STOKES,B.HURST,T.ROVIS,A.CHAVEZ,D.D.HO,B.R.STOCKWELL
REVDAT 4 06-NOV-24 7TIA 1 REMARK
REVDAT 3 18-OCT-23 7TIA 1 REMARK
REVDAT 2 11-MAY-22 7TIA 1 TITLE
REVDAT 1 04-MAY-22 7TIA 0
JRNL AUTH H.LIU,S.IKETANI,A.ZASK,N.KHANIZEMAN,E.BEDNAROVA,F.FOROUHAR,
JRNL AUTH 2 B.FOWLER,S.J.HONG,H.MOHRI,M.S.NAIR,Y.HUANG,N.E.S.TAY,S.LEE,
JRNL AUTH 3 C.KARAN,S.J.RESNICK,C.QUINN,W.LI,H.SHION,X.XIA,J.D.DANIELS,
JRNL AUTH 4 M.BARTOLO-CRUZ,M.FARINA,P.RAJBHANDARI,C.JURTSCHENKO,
JRNL AUTH 5 M.A.LAUBER,T.MCDONALD,M.E.STOKES,B.L.HURST,T.ROVIS,A.CHAVEZ,
JRNL AUTH 6 D.D.HO,B.R.STOCKWELL
JRNL TITL DEVELOPMENT OF OPTIMIZED DRUG-LIKE SMALL MOLECULE INHIBITORS
JRNL TITL 2 OF THE SARS-COV-2 3CL PROTEASE FOR TREATMENT OF COVID-19.
JRNL REF NAT COMMUN V. 13 1891 2022
JRNL REFN ESSN 2041-1723
JRNL PMID 35393402
JRNL DOI 10.1038/S41467-022-29413-2
REMARK 2
REMARK 2 RESOLUTION. 1.64 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX 1.17.1_3660
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : ML
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.64
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.17
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4
REMARK 3 NUMBER OF REFLECTIONS : 44624
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.174
REMARK 3 R VALUE (WORKING SET) : 0.173
REMARK 3 FREE R VALUE : 0.191
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.070
REMARK 3 FREE R VALUE TEST SET COUNT : 4495
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 47.1700 - 5.1000 0.98 1389 146 0.1459 0.1587
REMARK 3 2 5.0900 - 4.0500 0.98 1351 149 0.1323 0.1494
REMARK 3 3 4.0400 - 3.5300 0.99 1348 163 0.1610 0.1542
REMARK 3 4 3.5300 - 3.2100 0.98 1366 130 0.1832 0.2042
REMARK 3 5 3.2100 - 2.9800 0.99 1381 138 0.1891 0.1967
REMARK 3 6 2.9800 - 2.8000 0.99 1325 164 0.1946 0.2181
REMARK 3 7 2.8000 - 2.6600 0.98 1338 150 0.2003 0.2406
REMARK 3 8 2.6600 - 2.5500 0.99 1325 139 0.1885 0.2074
REMARK 3 9 2.5500 - 2.4500 0.99 1333 162 0.1941 0.2474
REMARK 3 10 2.4500 - 2.3700 0.99 1370 146 0.1880 0.2042
REMARK 3 11 2.3700 - 2.2900 0.99 1346 155 0.1900 0.2183
REMARK 3 12 2.2900 - 2.2300 0.99 1358 151 0.1909 0.2238
REMARK 3 13 2.2300 - 2.1700 0.99 1302 157 0.1868 0.2192
REMARK 3 14 2.1700 - 2.1100 0.99 1321 171 0.1823 0.2002
REMARK 3 15 2.1100 - 2.0700 0.99 1315 150 0.1868 0.2108
REMARK 3 16 2.0700 - 2.0200 0.99 1373 141 0.1954 0.2071
REMARK 3 17 2.0200 - 1.9800 0.99 1361 140 0.1817 0.2094
REMARK 3 18 1.9800 - 1.9400 0.99 1320 143 0.1821 0.2165
REMARK 3 19 1.9400 - 1.9100 0.98 1337 149 0.1856 0.1982
REMARK 3 20 1.9100 - 1.8800 0.98 1349 138 0.1812 0.1961
REMARK 3 21 1.8800 - 1.8500 0.98 1333 153 0.1694 0.2129
REMARK 3 22 1.8500 - 1.8200 0.98 1330 151 0.1777 0.2215
REMARK 3 23 1.8200 - 1.7900 0.98 1326 141 0.1858 0.2044
REMARK 3 24 1.7900 - 1.7700 0.98 1333 163 0.1848 0.1967
REMARK 3 25 1.7700 - 1.7400 0.98 1290 158 0.2090 0.2423
REMARK 3 26 1.7400 - 1.7200 0.98 1309 168 0.2016 0.2282
REMARK 3 27 1.7200 - 1.7000 0.97 1342 140 0.2151 0.2318
REMARK 3 28 1.7000 - 1.6800 0.98 1307 142 0.2280 0.2613
REMARK 3 29 1.6800 - 1.6600 0.98 1327 152 0.2397 0.2897
REMARK 3 30 1.6600 - 1.6400 0.97 1324 145 0.2609 0.2517
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.240
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.69
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : NULL NULL
REMARK 3 ANGLE : NULL NULL
REMARK 3 CHIRALITY : NULL NULL
REMARK 3 PLANARITY : NULL NULL
REMARK 3 DIHEDRAL : NULL NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 1
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: ALL
REMARK 3 ORIGIN FOR THE GROUP (A): -26.0405 12.4936 59.4222
REMARK 3 T TENSOR
REMARK 3 T11: 0.2035 T22: 0.2387
REMARK 3 T33: 0.2666 T12: -0.0179
REMARK 3 T13: -0.0129 T23: -0.0165
REMARK 3 L TENSOR
REMARK 3 L11: 0.7011 L22: 1.5180
REMARK 3 L33: 3.4639 L12: 0.5546
REMARK 3 L13: -0.2295 L23: 1.2015
REMARK 3 S TENSOR
REMARK 3 S11: 0.0636 S12: -0.0748 S13: -0.0560
REMARK 3 S21: 0.0247 S22: -0.0520 S23: -0.0667
REMARK 3 S31: -0.1379 S32: -0.0899 S33: 0.0104
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 7TIA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JAN-22.
REMARK 100 THE DEPOSITION ID IS D_1000262363.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 22-SEP-20
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 24-ID-C
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.979
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : AIMLESS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50967
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.570
REMARK 200 RESOLUTION RANGE LOW (A) : 47.170
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1
REMARK 200 DATA REDUNDANCY : 6.900
REMARK 200 R MERGE (I) : 0.05500
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.5000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.57
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.59
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : 1.70400
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.100
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: MOLREP
REMARK 200 STARTING MODEL: 7JSU
REMARK 200
REMARK 200 REMARK: BLOCK-SHAPED
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 55.77
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.78
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M POTASSIUM THIOCYANATE, 0.1 M
REMARK 280 SODIUM ACETATE, PH 5, AND 20% (W/V) PEG 8000, MICROBATCH,
REMARK 280 TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y,-Z
REMARK 290 3555 X+1/2,Y+1/2,Z
REMARK 290 4555 -X+1/2,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 48.77550
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.88900
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 48.77550
REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 40.88900
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 3120 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 25480 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -43.20643
REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 94.32753
REMARK 375
REMARK 375 SPECIAL POSITION
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL
REMARK 375 POSITIONS.
REMARK 375
REMARK 375 ATOM RES CSSEQI
REMARK 375 HOH A 556 LIES ON A SPECIAL POSITION.
REMARK 375 HOH A 628 LIES ON A SPECIAL POSITION.
REMARK 375 HOH A 662 LIES ON A SPECIAL POSITION.
REMARK 375 HOH A 668 LIES ON A SPECIAL POSITION.
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 THR A 304
REMARK 465 PHE A 305
REMARK 465 GLN A 306
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASP A 33 -131.88 53.04
REMARK 500 ASN A 51 77.02 -151.65
REMARK 500 ASN A 84 -124.27 56.51
REMARK 500 ALA A 191 63.47 -103.20
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH A 672 DISTANCE = 6.65 ANGSTROMS
DBREF 7TIA A 1 306 UNP P0DTC1 R1A_SARS2 3264 3569
SEQRES 1 A 306 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL
SEQRES 2 A 306 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR
SEQRES 3 A 306 LEU ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO
SEQRES 4 A 306 ARG HIS VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO
SEQRES 5 A 306 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN
SEQRES 6 A 306 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE
SEQRES 7 A 306 GLY HIS SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL
SEQRES 8 A 306 ASP THR ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL
SEQRES 9 A 306 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS
SEQRES 10 A 306 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET
SEQRES 11 A 306 ARG PRO ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY
SEQRES 12 A 306 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS
SEQRES 13 A 306 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR
SEQRES 14 A 306 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR
SEQRES 15 A 306 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY
SEQRES 16 A 306 THR ASP THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU
SEQRES 17 A 306 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN
SEQRES 18 A 306 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA
SEQRES 19 A 306 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL
SEQRES 20 A 306 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA
SEQRES 21 A 306 VAL LEU ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN
SEQRES 22 A 306 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU
SEQRES 23 A 306 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN
SEQRES 24 A 306 CYS SER GLY VAL THR PHE GLN
HET XTP A 401 29
HET SCN A 402 3
HETNAM XTP BENZYL [(2S)-3-CYCLOPROPYL-1-({(2S)-1-HYDROXY-3-[(3S)-
HETNAM 2 XTP 2-OXOPYRROLIDIN-3-YL]PROPAN-2-YL}AMINO)-1-OXOPROPAN-2-
HETNAM 3 XTP YL]CARBAMATE
HETNAM SCN THIOCYANATE ION
FORMUL 2 XTP C21 H29 N3 O5
FORMUL 3 SCN C N S 1-
FORMUL 4 HOH *170(H2 O)
HELIX 1 AA1 SER A 10 GLY A 15 1 6
HELIX 2 AA2 HIS A 41 CYS A 44 5 4
HELIX 3 AA3 GLU A 47 ASN A 51 5 5
HELIX 4 AA4 ASN A 53 ARG A 60 1 8
HELIX 5 AA5 SER A 62 HIS A 64 5 3
HELIX 6 AA6 ILE A 200 ASN A 214 1 15
HELIX 7 AA7 THR A 226 TYR A 237 1 12
HELIX 8 AA8 THR A 243 LEU A 250 1 8
HELIX 9 AA9 LEU A 250 GLY A 258 1 9
HELIX 10 AB1 ALA A 260 GLY A 275 1 16
HELIX 11 AB2 THR A 292 SER A 301 1 10
SHEET 1 AA1 7 VAL A 73 LEU A 75 0
SHEET 2 AA1 7 PHE A 66 ALA A 70 -1 N ALA A 70 O VAL A 73
SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N THR A 21 O LEU A 67
SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O THR A 25 N CYS A 22
SHEET 5 AA1 7 VAL A 35 PRO A 39 -1 O VAL A 35 N LEU A 32
SHEET 6 AA1 7 VAL A 86 VAL A 91 -1 O LEU A 87 N CYS A 38
SHEET 7 AA1 7 VAL A 77 GLN A 83 -1 N ILE A 78 O LYS A 90
SHEET 1 AA2 5 LYS A 100 PHE A 103 0
SHEET 2 AA2 5 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100
SHEET 3 AA2 5 VAL A 148 ASP A 153 -1 N ASN A 151 O SER A 158
SHEET 4 AA2 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150
SHEET 5 AA2 5 SER A 121 ALA A 129 -1 O TYR A 126 N VAL A 114
SHEET 1 AA3 3 LYS A 100 PHE A 103 0
SHEET 2 AA3 3 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100
SHEET 3 AA3 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165
LINK SG CYS A 145 C12 XTP A 401 1555 1555 1.81
CRYST1 97.551 81.778 51.876 90.00 114.61 90.00 C 1 2 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.010251 0.000000 0.004694 0.00000
SCALE2 0.000000 0.012228 0.000000 0.00000
SCALE3 0.000000 0.000000 0.021202 0.00000